Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclobenzaprine ER for Acute Muscle Spasms
NCT02814565Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclobenzaprine in muscle spasm, back pain, Cervicalgia, sponsored by Takeda. Started Oct 2016; status: completed.
02
Drugs
cyclobenzaprine
03
Conditions
muscle spasmback painCervicalgia
Beyond the preview
Go deeper on NCT02814565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02814565.